Please login to the form below

Not currently logged in
Email:
Password:

Hanover appoints Frances Beves as corp comms lead

She will join the agencynext month from Bell Pottinger

Hanover Frances BevesHanover has appointed Frances Beves as a director in its healthcare team, where she will lead its corporate communications team.

Beves will join the London-based healthcare communications agency next month from Bell Pottinger, which she served as a partner for two years.

Prior to this spent ten years in-house as Lilly's director of European communications, and also held international roles at GSK and GE Healthcare.

She said: “I am very excited to be joining Hanover. The company holds a distinctive position in the pharmaceutical space as it can provide senior counsel and campaigns in brand and corporate comms as well as market access and policy.

“I feel my skillset is well suited to Hanover's offering and I am delighted to be joining the team at a time of strong growth.”

The agency's director of global healthcare Andrew Harrison added: “Hanover's European and UK brand and corporate communications business has expanded over the last 18 months and we are really excited to welcome Frances to build and enhance this part of our business.

“She brings a wealth of knowledge and experience and her time in-house means that she has a depth of understanding of the needs of our clients.”

Hanover, whose recent account wins include Novo Nordisk's public affairs and policy account, has been expanding its healthcare team of late and now employs 20 people who work out of its London and Brussels offices, 

7th July 2015

From: Marketing

Share

Tags

PMEA Awards 2020

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Madmicrobe Studios

MadMicrobe is an award-winning team of certified medical illustrators creating animations that draw audiences into a world of suspense, excitement,...

Latest intelligence

EU health fund
An EU emergency health fund to limit the impact of future crises
Leading finance experts propose an Emergency Health Financing Facility to limit the impact of future crises on the EU...
Mistrust in medical research: a patient perspective
The recent development of several COVID-19 vaccines has placed medical research firmly in the spotlight, highlighting public confusion and misinformation about clinical trials. Patient advocate, Trishna Bharadia reveals what the...
Real-world evidence: breaking boundaries in rare disease
Generating data for drug launches is a challenging process. In rare diseases, with small patient populations and high unmet need, evidence generation is even more complex. Consultant Sarah Poole and...

Infographics